Skip to content

Influence of troublesome venipunctures on S-100B level in melanoma patients

Influence of troublesome venipunctures on S-100B level in melanoma patients - Influence of troublesome venipunctures on S-100B

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39996
Enrollment
22
Registered
2013-06-06
Start date
2013-08-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melanoma

Interventions

Venipuncture in healthy participants the needle will be injected at the cubital fossa of the upper forearm first in at least 1-2cm of sub cutis before injecting it in the vein.

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy participants with an age between 18 and 65 years old

Exclusion criteria

Exclusion criteria: A major disease of the nervous system or cancer, use of medication, recent heavy weight loss, major stress, recent extreme physical activity, pregnancy, use of soft/hard drugs or smoking. These criteria will be determined using a questionnaire.

Design outcomes

Primary

MeasureTime frame
S-100B will be measured in µg/L. The median level of S-100B is 0.10 µg/L, with a RCV of 41% a value higher than 0.14 *g/l will be a significantly higher value of S-100B.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)